semaglutide deaths 2024 The letter cited three among patients using semaglutide, the active ingredient in several of its weight-loss medications, which it said were not properly investigated or reported. Read more at the link Semaglutide reduces risk of all-cause

The placebo group barely changed

The most important underlying message is that the purpose of these supplements is to supplement, not substitute, a nutrient-rich diet

PubMed ID: 10828840 Gobburu JV et al

Figure 2 However, significant heterogeneity in EPA/DHA dosing (0.53 g/d) and ratios across studies, short trial durations (typically 6 months), and a lack of robust structural outcome data (e.g., joint space narrowing) have precluded their formal recommendation as a standard adjunctive treatment in clinical guidelines (44)

Downstream effectors of mTOR including hypoxia-induced factor-1 (HIF-1), hexokinase (HK), pyruvate kinase M2 (PKM2), and enolase2 will then directly stimulate aerobic glycolysis and inhibit oxidative phosphorylation in cancer cells, thus leading to the metabolic reprogramming in PDA tissue (Yang et al., 2019

Though it does not provide protection in the UVA1 (340-400 nm) range, it does have a boosting effect there